Cipla surges on collaborating with S&D Pharma to enter Czech Republic and Slovakia

09 Sep 2014 Evaluate

Cipla is currently trading at Rs. 570.20, up by 6.80 points or 1.21% from its previous closing of Rs. 563.40 on the BSE.

The scrip opened at Rs. 566.00 and has touched a high and low of Rs. 572.80 and Rs. 566.00 respectively. So far 85051 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 575.20 on 02-Sep-2014 and a 52 week low of Rs. 366.70 on 24-Feb-2014.

Last one week high and low of the scrip stood at Rs. 575.20 and Rs. 532.10 respectively. The current market cap of the company is Rs. 45605.93 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 35.85% and 26.23% respectively.

Cipla, a global pharmaceutical company, has collaborated with S&D Pharma in the Czech Republic and Slovakia. This collaboration will enable Cipla to focus on its core therapy areas, while S&D Pharma will be the key partner for generics.

Under the collaboration, Cipla will be driving its respiratory product portfolio in both Czech Republic and Slovakia through a Cipla owned sales force team, managed by Cipla commercial head. S&D Pharma will physically distribute all products, including respiratory products, and this portfolio will increase over the next few years.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.

Cipla Share Price

1497.00 -8.05 (-0.53%)
29-Dec-2025 13:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.45
Dr. Reddys Lab 1264.70
Cipla 1497.00
Zydus Lifesciences 903.70
Lupin 2084.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×